Skip to product information
1 of 1

Elabscience

SKU:PKSH031899

Recombinant Human ALK-1/ACVRL1 Protein (Fc Tag)(Active)

Recombinant Human ALK-1/ACVRL1 Protein (Fc Tag)(Active)

Regular price $670.00 USD
Regular price Sale price $670.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
Introducing the Recombinant Human ALK-1/ACVRL1 Protein (Fc Tag)(Active), a cutting-edge product designed to revolutionize the field of biotechnology. This protein, derived from human sources, has been meticulously engineered using recombinant technology to ensure its utmost purity and efficacy.

The Recombinant Human ALK-1/ACVRL1 Protein (Fc Tag)(Active) boasts an impressive array of features that set it apart from conventional alternatives. With the addition of a Fc tag, this protein exhibits enhanced stability and prolonged half-life, enabling it to exert its biological functions with remarkable efficiency.

This active variant of the ALK-1/ACVRL1 protein is specifically tailored to facilitate a wide range of applications in various research areas. Its inherent ability to bind to ligands and activate downstream signaling pathways makes it an invaluable tool for investigating the intricate mechanisms underlying angiogenesis, vascular development, and related physiological processes.

Furthermore, the Recombinant Human ALK-1/ACVRL1 Protein (Fc Tag)(Active) is manufactured under stringent quality control measures, ensuring batch-to-batch consistency and reproducibility. Its high bioactivity and purity make it an ideal choice for both in vitro and in vivo studies, enabling researchers to obtain reliable and accurate results.

In summary, the Recombinant Human ALK-1/ACVRL1 Protein (Fc Tag)(Active) represents a breakthrough in the field of biotechnology, offering researchers an unparalleled tool to unravel the complexities of angiogenesis and vascular development. With its exceptional stability, enhanced half-life, and remarkable bioactivity, this protein is poised to revolutionize scientific investigations and pave the way for groundbreaking discoveries.
View full details